http://www.clinicaladvisor.com/chronic-cancer-pain/topic/12549/ Articles tagged with Chronic Cancer Pain from The Clinical Advisor Clinical Advisor custserv@haymarketmedia.com no The term "contract" when used in regard to agreements with patients who have chronic pain is dated, perceived negatively and not preferred. http://www.clinicaladvisor.com/implementing-new-pain-management-terminology/article/231303/ Thu, 08 Mar 2012 23:25:41 GMT The term "contract" when used in regard to agreements with patients who have chronic pain is dated, perceived negatively and not preferred. Clinical Advisor Fentanyl nasal spray is indicated for breakthrough pain in opioid-tolerant patients who are already receiving and tolerant to continuous opioid therapy for underlying persistent cancer pain. http://www.clinicaladvisor.com/fentanyl-nasal-spray-manages-cancer-pain/article/219805/ Sun, 18 Dec 2011 18:00:00 GMT Fentanyl nasal spray is indicated for breakthrough pain in opioid-tolerant patients who are already receiving and tolerant to continuous opioid therapy for underlying persistent cancer pain. Clinical Advisor Variability in baseline breakthrough pain (BTP) has no impact on the analgesic response to sublingual fentanyl tablets or placebo. http://www.clinicaladvisor.com/breakthrough-pain-variability-has-no-impact-on-response-to-sublingual-fentanyl-tablets-or-placebo/article/203265/ Thu, 19 May 2011 22:03:56 GMT Variability in baseline breakthrough pain (BTP) has no impact on the analgesic response to sublingual fentanyl tablets or placebo. Clinical Advisor